Becton Dickinson stock, medical technology

Becton, Dickinson stock gained 2.56 percent on September 25

Published on 09/28/2026 at 15:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Becton, Dickinson stock stood at USD 183.82 on September 25, 4.79 percent below its 52-week high. Q3 revenue reached USD 4.98 billion and adjusted EPS was USD 3.23.

Steriler Reinraum mit Mitarbeitern an der Produktionslinie für Medizinprodukte
Becton Dickinson betreibt moderne Reinraum Fertigungsanlagen für Medizinprodukte weltweit, ISIN US0718131099 NYSE, Illustration mit AI erstellt.

Becton, Dickinson and Company stock was last at USD 183.82 on the NYSE on September 25, 2026 at 4:00 p.m. ET, up 2.56 percent from the prior close of USD 179.23. The latest quarterly report delivered the fundamental catalyst: Q3 fiscal 2026 revenue reached USD 4.98 billion and adjusted EPS came to USD 3.23.

Quarterly results beat expectations

For the quarter ended June 30, 2026, BD reported total revenue of USD 5.0 billion and adjusted EPS of USD 3.23. The companys investor page identifies both figures as Q3 fiscal 2026 results and classifies adjusted EPS as a non-GAAP measure.

MarketBeat reported on September 25, 2026, that adjusted EPS exceeded the USD 3.14 consensus by USD 0.09, while revenue surpassed the USD 4.89 billion estimate. Revenue was up 5.4 percent from the comparable prior-year quarter.

Guidance supports the valuation

MarketBeat said fiscal 2026 adjusted EPS guidance stood at USD 12.62-12.72, with analyst consensus at USD 12.67. That range places the current fiscal-year outlook above the latest quarterly adjusted EPS figure of USD 3.23 on a full-year basis, although the two figures cover different periods.

The same September 25 report placed the analyst consensus at Hold, with eight Buy, eight Hold and one Sell rating. The average 12-month price target was USD 187.67, which lies 2.09 percent above the September 25 reference price of USD 183.82.

Stock remains below its yearly high

BDX traded between USD 177.87 and USD 183.92 on September 25, 2026, with volume of 1,448,984 shares. Its 52-week range was USD 127.59 to USD 193.07, leaving the reference price 4.79 percent below the yearly high.

Market capitalization stood at USD 50.6 billion as of September 25, 2026. The next scheduled earnings date shown by Investing.com is November 5, 2026, keeping the next reporting checkpoint visible after the Q3 results.

Becton Dickinson stock snapshot

  • Company: Becton, Dickinson and Company
  • Ticker: BDX
  • Trading venue: NYSE
  • Price as of September 25, 2026, 4:00 p.m. ET: USD 183.82
  • Market capitalization: USD 50.6 billion as of September 25, 2026
  • 52-week range: USD 127.59-193.07
  • Sector / Industry: Healthcare / Medical Instruments and Supplies
  • Next earnings date: November 5, 2026

Disclaimer...

en | boerse | 70193042 |